Announced
Completed
A consortium of investors led a $270m funding round in Yaoshibang.
Synopsis
A consortium of investors led a $270m funding round in Yaoshibang, a Chinese pharmaceutical trading platform. The consortium consisted of Zhejiang Pearl River Investment Management, Baidu, Green Pine Capital Partners and Guangzhou City Construction Investment. Following the investment, Yaoshibang will look to upgrade digital sales, marketing systems, and its data-sharing platform.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.